Cita APA (7a ed.)
Shook, L. M., Haygood, D., & Quinn, C. T. (2025). Clinical Utility of the Addition of Molecular Genetic Testing to Newborn Screening for Hemoglobinopathies for Confirmation of Alpha-Thalassemia Trait. International Journal of Neonatal Screening (IJNS), 11(1), 12-21.
Cita Chicago Style (17a ed.)
Shook, Lisa M., Deidra Haygood, y Charles T. Quinn. "Clinical Utility of the Addition of Molecular Genetic Testing to Newborn Screening for Hemoglobinopathies for Confirmation of Alpha-Thalassemia Trait." International Journal of Neonatal Screening (IJNS) 11, no. 1 (2025): 12-21.
Cita MLA (9a ed.)
Shook, Lisa M., et al. "Clinical Utility of the Addition of Molecular Genetic Testing to Newborn Screening for Hemoglobinopathies for Confirmation of Alpha-Thalassemia Trait." International Journal of Neonatal Screening (IJNS), vol. 11, no. 1, 2025, pp. 12-21.
Precaución: Estas citas no son 100% exactas.